Literature DB >> 22258766

SPINDLIN1 promotes cancer cell proliferation through activation of WNT/TCF-4 signaling.

Jing-Xue Wang1, Quan Zeng, Lin Chen, Ji-Chao Du, Xin-Long Yan, Hong-Feng Yuan, Chao Zhai, Jun-Nian Zhou, Ya-Li Jia, Wen Yue, Xue-Tao Pei.   

Abstract

SPINDLIN1, a new member of the SPIN/SSTY gene family, was first identified as a gene highly expressed in ovarian cancer cells. We have previously shown that it is involved in the process of spindle organization and chromosomal stability and plays a role in the development of cancer. Nevertheless, the mechanisms underlying its oncogenic role are still largely unknown. Here, we first showed that expression of SPINDLIN1 is upregulated in clinical tumors. Ectopic expression of SPINDLIN1 promoted cancer cell proliferation and activated WNT/T-cell factor (TCF)-4 signaling. The Ser84 and Ser99 amino acids within SPINDLIN1 were further identified as the key functional sites in WNT/TCF-4 signaling activation. Mutation of these two sites of SPINDLIN1 abolished its effects on promoting WNT/TCF-4 signaling and cancer cell proliferation. We further found that Aurora-A could interact with and phosphorylate SPINDLIN1 at its key functional sites, Ser84 and Ser99, suggesting that phosphorylation of SPINDLIN1 is involved in its oncogenic function. Collectively, these results suggest that SPINDLIN1, which may be a novel substrate of the Aurora-A kinase, promotes cancer cell growth through WNT/TCF-4 signaling activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258766     DOI: 10.1158/1541-7786.MCR-11-0440

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  25 in total

1.  Developing Spindlin1 small-molecule inhibitors by using protein microarrays.

Authors:  Narkhyun Bae; Monica Viviano; Xiaonan Su; Jie Lv; Donghang Cheng; Cari Sagum; Sabrina Castellano; Xue Bai; Claire Johnson; Mahmoud Ibrahim Khalil; Jianjun Shen; Kaifu Chen; Haitao Li; Gianluca Sbardella; Mark T Bedford
Journal:  Nat Chem Biol       Date:  2017-05-15       Impact factor: 15.040

2.  Identification of a small-molecule ligand of the epigenetic reader protein Spindlin1 via a versatile screening platform.

Authors:  Tobias Wagner; Holger Greschik; Teresa Burgahn; Karin Schmidtkunz; Anne-Kathrin Schott; Joel McMillan; Lina Baranauskienė; Yan Xiong; Oleg Fedorov; Jian Jin; Udo Oppermann; Daumantas Matulis; Roland Schüle; Manfred Jung
Journal:  Nucleic Acids Res       Date:  2016-02-17       Impact factor: 16.971

3.  A transcriptional coregulator, SPIN·DOC, attenuates the coactivator activity of Spindlin1.

Authors:  Narkhyun Bae; Min Gao; Xu Li; Tolkappiyan Premkumar; Gianluca Sbardella; Junjie Chen; Mark T Bedford
Journal:  J Biol Chem       Date:  2017-10-23       Impact factor: 5.157

4.  SPINDOC is Highly Expressed in Pan-Cancer Samples and Can Promote the Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating Wnt/β-Catenin Signaling Pathway.

Authors:  Wangxia Tong; Lilan Yang; Li Liu; Xudong Liu; Ning Luo
Journal:  Onco Targets Ther       Date:  2022-05-18       Impact factor: 4.345

5.  The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene Expression.

Authors:  Sophie S B Giguère; Amanda J Guise; Pierre M Jean Beltran; Preeti M Joshi; Todd M Greco; Olivia L Quach; Jeffery Kong; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2015-12-09       Impact factor: 5.911

6.  The histone code reader SPIN1 controls RET signaling in liposarcoma.

Authors:  Henriette Franz; Holger Greschik; Dominica Willmann; Luka Ozretić; Cordula Annette Jilg; Eva Wardelmann; Manfred Jung; Reinhard Buettner; Roland Schüle
Journal:  Oncotarget       Date:  2015-03-10

7.  Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.

Authors:  Rosa Drago-Ferrante; Francesca Pentimalli; Daniela Carlisi; Anna De Blasio; Christian Saliba; Shawn Baldacchino; James Degaetano; Joseph Debono; Gordon Caruana-Dingli; Godfrey Grech; Christian Scerri; Giovanni Tesoriere; Antonio Giordano; Renza Vento; Riccardo Di Fiore
Journal:  Oncotarget       Date:  2017-04-25

8.  Structure-Based Design, Docking and Binding Free Energy Calculations of A366 Derivatives as Spindlin1 Inhibitors.

Authors:  Chiara Luise; Dina Robaa; Pierre Regenass; David Maurer; Dmytro Ostrovskyi; Ludwig Seifert; Johannes Bacher; Teresa Burgahn; Tobias Wagner; Johannes Seitz; Holger Greschik; Kwang-Su Park; Yan Xiong; Jian Jin; Roland Schüle; Bernhard Breit; Manfred Jung; Wolfgang Sippl
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

9.  Molecular basis underlying histone H3 lysine-arginine methylation pattern readout by Spin/Ssty repeats of Spindlin1.

Authors:  Xiaonan Su; Guixin Zhu; Xiaozhe Ding; Shirley Y Lee; Yali Dou; Bing Zhu; Wei Wu; Haitao Li
Journal:  Genes Dev       Date:  2014-03-03       Impact factor: 11.361

10.  The Tudor domain protein Spindlin1 is involved in intrinsic antiviral defense against incoming hepatitis B Virus and herpes simplex virus type 1.

Authors:  Aurélie Ducroux; Shirine Benhenda; Lise Rivière; O John Semmes; Monsef Benkirane; Christine Neuveut
Journal:  PLoS Pathog       Date:  2014-09-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.